If you're seeing this message, that means JavaScript has been disabled on your browser , pleaseenable JS to make this app work. Get Updates
396 Followers on Owler
Passage Bio Funding History Since Passage Bio was founded in 2017, it has participated in 3 rounds of funding. In total Passage Bio has raised $441.5M. Passage Bio's last funding round was on Feb 2020 for a total of $216.0M. Passage Bio Funding Rounds Series B
Sep 2019
$110M
11
Access Biotechnology ,
OrbiMed ,
Frazier Healthcare Partners ,
Versant Ventures ,
Lily Asia Ventures ,
New Leaf Venture Partners ,
Vivo Capital ,
Boxer Capital ,
Highline Capital Management ,
Logos Capital ,
Sphera Funds Management Passage Bio Investors Series B, Series A
Sep 2019, Feb 2019
Series B, Series A
Sep 2019, Feb 2019
Passage Bio has 13 investors, including Access Biotechnology, OrbiMed and Frazier Healthcare Partners. The latest investment occurred in Feb 2020. 
